nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Combination therapies for systemic sclerosis
|
Denton, C. P. |
|
2001 |
23 |
1-2 |
p. 109-129 |
artikel |
2 |
Combination therapies for systemic sclerosis
|
Denton, C. P. |
|
|
23 |
1-2 |
p. 109-129 |
artikel |
3 |
Combination therapy for autoimmune diseases: the rheumatoid arthritis model
|
Fathy, N. |
|
2001 |
23 |
1-2 |
p. 5-26 |
artikel |
4 |
Combination therapy for autoimmune diseases: the rheumatoid arthritis model
|
Fathy, N. |
|
|
23 |
1-2 |
p. 5-26 |
artikel |
5 |
Combination therapy in autoimmune disease: vasculitis
|
Carruthers, David M. |
|
2001 |
23 |
1-2 |
p. 91-108 |
artikel |
6 |
Combination therapy in autoimmune disease: vasculitis
|
Carruthers, David M. |
|
|
23 |
1-2 |
p. 91-108 |
artikel |
7 |
Combination therapy in rheumatoid arthritis
|
Bingham, S. |
|
2001 |
23 |
1-2 |
p. 165-183 |
artikel |
8 |
Combination therapy in rheumatoid arthritis
|
Bingham, S. |
|
|
23 |
1-2 |
p. 165-183 |
artikel |
9 |
Combination therapy: the risks of infection and tumor induction
|
Yocum, David E. |
|
2001 |
23 |
1-2 |
p. 63-72 |
artikel |
10 |
Combination therapy: the risks of infection and tumor induction
|
Yocum, David E. |
|
|
23 |
1-2 |
p. 63-72 |
artikel |
11 |
Combination treatment in autoimmune diseases — Introduction
|
Harrison, W. B. |
|
2001 |
23 |
1-2 |
p. 3-4 |
artikel |
12 |
Combination treatment in autoimmune diseases: systemic lupus erythematosus
|
Moroni, G. |
|
2001 |
23 |
1-2 |
p. 75-89 |
artikel |
13 |
Combination treatment in autoimmune diseases: systemic lupus erythematosus
|
Moroni, G. |
|
|
23 |
1-2 |
p. 75-89 |
artikel |
14 |
Methodology of combination trials
|
Boers, M. |
|
2001 |
23 |
1-2 |
p. 27-33 |
artikel |
15 |
Methodology of combination trials
|
Boers, M. |
|
|
23 |
1-2 |
p. 27-33 |
artikel |
16 |
New therapies in development for autoimmune diseases: their rationale for combination treatment
|
Strand, Vibeke |
|
2001 |
23 |
1-2 |
p. 43-61 |
artikel |
17 |
New therapies in development for autoimmune diseases: their rationale for combination treatment
|
Strand, Vibeke |
|
|
23 |
1-2 |
p. 43-61 |
artikel |
18 |
Regulatory aspects of evaluating combination treatments in autoimmune diseases
|
Kurki, Pekka |
|
2001 |
23 |
1-2 |
p. 35-41 |
artikel |
19 |
Regulatory aspects of evaluating combination treatments in autoimmune diseases
|
Kurki, Pekka |
|
|
23 |
1-2 |
p. 35-41 |
artikel |
20 |
Spondylarthropathies: options for combination therapy
|
Tubergen, A. M. van |
|
2001 |
23 |
1-2 |
p. 147-163 |
artikel |
21 |
Spondylarthropathies: options for combination therapy
|
van Tubergen, A. M. |
|
|
23 |
1-2 |
p. 147-163 |
artikel |
22 |
Stem cell transplantation for autoimmune diseases
|
Moore, John |
|
2001 |
23 |
1-2 |
p. 193-213 |
artikel |
23 |
Stem cell transplantation for autoimmune diseases
|
Moore, John |
|
|
23 |
1-2 |
p. 193-213 |
artikel |
24 |
Therapy of Sjögren’s syndrome
|
Moutsopoulos, Niki M. |
|
2001 |
23 |
1-2 |
p. 131-145 |
artikel |
25 |
Therapy of Sjögren’s syndrome
|
Moutsopoulos, Niki M. |
|
|
23 |
1-2 |
p. 131-145 |
artikel |
26 |
What will treatment of autoimmune diseases entail in 2010?
|
Huizinga, Tom W. J. |
|
2001 |
23 |
1-2 |
p. 187-192 |
artikel |
27 |
What will treatment of autoimmune diseases entail in 2010?
|
Huizinga, Tom W. J. |
|
|
23 |
1-2 |
p. 187-192 |
artikel |